相似文献
1
Response to Commentary on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients".
J Med Virol. 2020 Jul;92(7):707-709. doi: 10.1002/jmv.25824. Epub 2020 Apr 10.
2
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.
J Med Virol. 2020 Jun;92(6):552-555. doi: 10.1002/jmv.25728. Epub 2020 Mar 11.
3
Comment on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients".
J Med Virol. 2020 Jul;92(7):703-704. doi: 10.1002/jmv.25960. Epub 2020 May 22.
4
Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19.
ACS Chem Neurosci. 2020 Aug 19;11(16):2416-2421. doi: 10.1021/acschemneuro.0c00349. Epub 2020 Aug 11.
5
Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
ASN Neuro. 2020 Jan-Dec;12:1759091420954960. doi: 10.1177/1759091420954960.
6
The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients.
J Med Virol. 2020 Jul;92(7):786-790. doi: 10.1002/jmv.25918. Epub 2020 Apr 29.
7
Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
Neurol Sci. 2020 Oct;41(10):2657-2669. doi: 10.1007/s10072-020-04575-3. Epub 2020 Jul 28.
8
The involvement of the central nervous system in patients with COVID-19.
Rev Neurosci. 2020 May 26;31(4):453-456. doi: 10.1515/revneuro-2020-0026.
9
Pangolins Harbor SARS-CoV-2-Related Coronaviruses.
Trends Microbiol. 2020 Jul;28(7):515-517. doi: 10.1016/j.tim.2020.04.001. Epub 2020 Apr 6.
10
Managing neonates with respiratory failure due to SARS-CoV-2.
Lancet Child Adolesc Health. 2020 Apr;4(4):e8. doi: 10.1016/S2352-4642(20)30073-0. Epub 2020 Mar 6.
引用本文的文献
1
Refueling the post COVID-19 brain: potential role of ketogenic medium chain triglyceride supplementation: an hypothesis.
Front Nutr. 2023 Jun 21;10:1126534. doi: 10.3389/fnut.2023.1126534. eCollection 2023.
2
Ginkgo Biloba and Long COVID: In Vivo and In Vitro Models for the Evaluation of Nanotherapeutic Efficacy.
Pharmaceutics. 2023 May 22;15(5):1562. doi: 10.3390/pharmaceutics15051562.
3
Association of COVID-19 with Comorbidities: An Update.
ACS Pharmacol Transl Sci. 2023 Feb 27;6(3):334-354. doi: 10.1021/acsptsci.2c00181. eCollection 2023 Mar 10.
4
Respiratory issues in patients with multiple sclerosis as a risk factor during SARS-CoV-2 infection: a potential role for exercise.
Mol Cell Biochem. 2023 Jul;478(7):1533-1559. doi: 10.1007/s11010-022-04610-1. Epub 2022 Nov 21.
5
Neuroprotective Drug Discovery From Phytochemicals and Metabolites for CNS Viral Infection: A Systems Biology Approach With Clinical and Imaging Validation.
Front Neurosci. 2022 Jul 25;16:917867. doi: 10.3389/fnins.2022.917867. eCollection 2022.
6
Influence of traditional Chinese medicines on the metabolism of lopinavir/ritonavir based on UHPLC-MS/MS analysis.
J Pharm Anal. 2022 Apr;12(2):270-277. doi: 10.1016/j.jpha.2021.06.006. Epub 2021 Jun 25.
7
COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality.
Biomed Pharmacother. 2022 Jul;151:113089. doi: 10.1016/j.biopha.2022.113089. Epub 2022 May 8.
8
Multimodal Benefits of Exercise in Patients With Multiple Sclerosis and COVID-19.
Front Physiol. 2022 Apr 14;13:783251. doi: 10.3389/fphys.2022.783251. eCollection 2022.
9
Exploring the Clinical Utility of Gustatory Dysfunction (GD) as a Triage Symptom Prior to Reverse Transcription Polymerase Chain Reaction (RT-PCR) in the Diagnosis of COVID-19: A Meta-Analysis and Systematic Review.
Life (Basel). 2021 Nov 29;11(12):1315. doi: 10.3390/life11121315.
10
Molecular Mechanisms of Proteins - Targets for SARS-CoV-2 (Review).
Sovrem Tekhnologii Med. 2021;12(6):98-108. doi: 10.17691/stm2020.12.6.11. Epub 2020 Dec 28.
本文引用的文献
1
Respiratory failure alone does not suggest central nervous system invasion by SARS-CoV-2.
J Med Virol. 2020 Jul;92(7):705-706. doi: 10.1002/jmv.25828. Epub 2020 Apr 24.
2
Global approaches for global challenges: The possible support of rehabilitation in the management of COVID-19.
J Med Virol. 2020 Oct;92(10):1739-1740. doi: 10.1002/jmv.25829. Epub 2020 Apr 8.
3
Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms.
ACS Chem Neurosci. 2020 Apr 1;11(7):995-998. doi: 10.1021/acschemneuro.0c00122. Epub 2020 Mar 13.
4
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.
J Med Virol. 2020 Jun;92(6):552-555. doi: 10.1002/jmv.25728. Epub 2020 Mar 11.
5
A Locally Transmitted Case of SARS-CoV-2 Infection in Taiwan.
N Engl J Med. 2020 Mar 12;382(11):1070-1072. doi: 10.1056/NEJMc2001573. Epub 2020 Feb 12.
6
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
7
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
8
Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4.
J Infect Dis. 2016 Mar 1;213(5):712-22. doi: 10.1093/infdis/jiv499. Epub 2015 Oct 20.
9
Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2.
J Virol. 2008 Aug;82(15):7264-75. doi: 10.1128/JVI.00737-08. Epub 2008 May 21.
10
Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus.
J Virol. 2007 Jan;81(2):813-21. doi: 10.1128/JVI.02012-06. Epub 2006 Nov 1.
Zotero 插件